Spero Therapeutics, Inc.
USD2.80
-0.03 (-1.06%)
CEO
Esther Rajavelu
IPO Date
2017-11-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.85
Prev. Close
$2.83
Day Low
$2.77
Day High
$2.86
52W Low
$1.80
52W High
$3.22
Market Cap
$0.16B
Volume
0.77M
| 37,101 |
| $2.36 |
| 9 Feb 2026 | Rajavelu Esther | See Remarks | S-Sale | Disposed | 50,816 | $2.36 |
| 9 Feb 2026 | Keutzer Timothy | Chief Operating Officer | S-Sale | Disposed | 18,652 | $2.36 |
| 5 Feb 2026 | Keutzer Timothy | Chief Operating Officer | S-Sale | Disposed | 24,224 | $2.14 |
| 5 Feb 2026 | Keutzer Timothy | Chief Operating Officer | S-Sale | Disposed | 3,471 | $2.24 |
| 5 Feb 2026 | Keutzer Timothy | Chief Operating Officer | A-Award | Acquired | 137,000 | $2.23 |
| 5 Feb 2026 | Keutzer Timothy | Chief Operating Officer | A-Award | Acquired | 68,000 | $0.00 |
| 5 Feb 2026 | Keutzer Timothy | Chief Operating Officer | S-Sale | Disposed | 18,891 | $2.20 |
| 4 Feb 2026 | Rajavelu Esther | See Remarks | A-Award | Acquired | 249,000 | $0.00 |